Janus Henderson Group PLC Sells 1,172,600 Shares of DENTSPLY SIRONA Inc. (NASDAQ:XRAY)

Janus Henderson Group PLC lessened its holdings in DENTSPLY SIRONA Inc. (NASDAQ:XRAYFree Report) by 15.5% during the 3rd quarter, HoldingsChannel reports. The firm owned 6,389,767 shares of the medical instruments supplier’s stock after selling 1,172,600 shares during the period. Janus Henderson Group PLC’s holdings in DENTSPLY SIRONA were worth $172,907,000 at the end of the most recent reporting period.

Several other institutional investors have also bought and sold shares of the business. Paloma Partners Management Co purchased a new stake in shares of DENTSPLY SIRONA during the 3rd quarter valued at about $402,000. Edgestream Partners L.P. bought a new stake in DENTSPLY SIRONA during the third quarter worth approximately $3,990,000. Capstone Investment Advisors LLC purchased a new stake in DENTSPLY SIRONA during the third quarter valued at approximately $209,000. Financial Counselors Inc. lifted its stake in shares of DENTSPLY SIRONA by 2.4% in the 3rd quarter. Financial Counselors Inc. now owns 240,712 shares of the medical instruments supplier’s stock valued at $6,514,000 after purchasing an additional 5,633 shares during the last quarter. Finally, FORA Capital LLC purchased a new position in shares of DENTSPLY SIRONA in the 3rd quarter worth approximately $719,000. Institutional investors own 95.70% of the company’s stock.

Analyst Upgrades and Downgrades

XRAY has been the subject of a number of analyst reports. Leerink Partnrs downgraded DENTSPLY SIRONA from a “strong-buy” rating to a “hold” rating in a research report on Thursday, November 7th. Robert W. Baird lowered their target price on shares of DENTSPLY SIRONA from $31.00 to $24.00 and set a “neutral” rating for the company in a report on Friday, November 8th. Barrington Research dropped their price target on shares of DENTSPLY SIRONA from $36.00 to $24.00 and set an “outperform” rating for the company in a research note on Friday, November 8th. Leerink Partners lowered shares of DENTSPLY SIRONA from an “outperform” rating to a “market perform” rating in a research report on Thursday, November 7th. Finally, Needham & Company LLC cut their target price on DENTSPLY SIRONA from $34.00 to $29.00 and set a “buy” rating on the stock in a research note on Friday, October 25th. Seven equities research analysts have rated the stock with a hold rating and four have given a buy rating to the company. According to MarketBeat.com, the company presently has a consensus rating of “Hold” and a consensus price target of $29.22.

Read Our Latest Analysis on XRAY

DENTSPLY SIRONA Stock Down 2.2 %

Shares of NASDAQ XRAY opened at $19.39 on Wednesday. DENTSPLY SIRONA Inc. has a 52-week low of $17.21 and a 52-week high of $37.60. The firm has a market capitalization of $3.85 billion, a price-to-earnings ratio of -9.37, a PEG ratio of 1.94 and a beta of 0.96. The stock has a 50 day moving average price of $22.29 and a 200 day moving average price of $24.62. The company has a debt-to-equity ratio of 0.72, a quick ratio of 0.84 and a current ratio of 1.25.

DENTSPLY SIRONA (NASDAQ:XRAYGet Free Report) last issued its earnings results on Thursday, November 7th. The medical instruments supplier reported $0.50 earnings per share for the quarter, topping the consensus estimate of $0.48 by $0.02. The business had revenue of $951.00 million during the quarter, compared to analysts’ expectations of $939.10 million. DENTSPLY SIRONA had a positive return on equity of 12.62% and a negative net margin of 10.59%. The business’s revenue for the quarter was up .4% compared to the same quarter last year. During the same period in the prior year, the business earned $0.49 EPS. Sell-side analysts expect that DENTSPLY SIRONA Inc. will post 1.84 earnings per share for the current year.

DENTSPLY SIRONA Company Profile

(Free Report)

DENTSPLY SIRONA Inc manufactures and sells various dental products and technologies worldwide. It operates in four segments: Connected Technology Solutions, Essential Dental Solutions, Orthodontic and Implant Solutions, and Wellspect Healthcare. The company offers dental equipment comprising imaging equipment, motorized dental handpieces, treatment centers, other instruments, amalgamators, mixing machines, and porcelain furnaces; and dental CAD/CAM technologies to support dental restorations, such as intraoral scanners, 3-D printers, mills, other software and services, and a full-chairside economical restoration of esthetic ceramic dentistry, as well as DS Core, its cloud-based platform.

Read More

Want to see what other hedge funds are holding XRAY? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for DENTSPLY SIRONA Inc. (NASDAQ:XRAYFree Report).

Institutional Ownership by Quarter for DENTSPLY SIRONA (NASDAQ:XRAY)

Receive News & Ratings for DENTSPLY SIRONA Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for DENTSPLY SIRONA and related companies with MarketBeat.com's FREE daily email newsletter.